Synonym:
4-amino-1-hydroxy-1-phosphonobutyl phosphonic acid, monosodium,
Alendronate sodium trihydrate,
MK-217
Properties:
| Related Categories |
Analytical Standards,
Analytical/Chromatography,
EP Standards,
EP Standards S - T,
Pharmacopeia & Metrological Institutes Standards
|
Description:
Biochem/physiol Actions
Alendronate sodium trihydrate is a bone resorption inhibitor; farnesyl diphosphate synthase inhibitor (IC50 = 460 nM); CD45 protein tyrosine phosphatase inhibitor.
Caution
Please find SDS provided by EDQM here.
.
General description
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia
.
Other Notes
Sales restrictions may apply.
Packaging
Unit quantity: 150 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue
.
Safety:
Symbol

GHS07
Precautionary statements
P301 + P312 + P330
RIDADR
NONH for all modes of transport